Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 3.7 Certificate of Amendment to Third Amended and Restated Certificate of Incorporation of Felicitex Therapeutics Inc
- 4.1 Form of Representative's Warrant
- 4.2 Form of Warrant Agent Agreement
- 10.29 Sublease Between Felicitex Therapeutics Inc. and Quateris, LLC, Dated March 15, 2017
- 10.37 Material Transfer and Agreement Between Felicitex Therapeutics Inc. and Barbara Ann Karmanos Cancer Institute, Dated July 18, 2022***
- 10.38 Form of Stock Option Agreement for Felicitex Therapeutics Inc. 2022 Equity Incentive Plan
- 10.39 Form of Restricted Stock Award Agreement for Felicitex Therapeutics Inc. 2022 Equity Incentive Plan
- 10.40 Form of Restricted Stock Unit Award Agreement for Felicitex Therapeutics Inc. 2022 Equity Incentive Plan
- 10.41 Engagement Letter Agreement Between Felicitex Therapeutics Inc. and A.t. Healey, LLC, Dated April 1, 2021
- 10.42 Employment Letter Agreement Between Felicitex Therapeutics Inc. and Arthur Healey Dated September 6, 2022
- 23.1 Consent of Friedman LLP
- 99.4 Consent of Michael Kody to Be Named As a Director Nominee
Associated filings
- 8 Dec 22 S-1/A IPO registration (amended)
- 30 Nov 22 S-1/A IPO registration (amended)
- 31 Oct 22 S-1/A IPO registration (amended)
-
16 Sep 22 S-1/A IPO registration (amended)
- 10 Aug 22 S-1 IPO registration
FLCT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Amendment No. 1 to the Registration Statement on Form S-1 of our report dated March 22, 2022, except for Note 1 and Note 15, as to which the date is June 2, 2022, which includes an explanatory paragraph as to the company’s ability to continue as going concern, with respect to the consolidated and combined financial statements of Felicitex Therapeutics, Inc. as of December 31, 2021 and 2020 and for the years then ended. We also consent to the reference of our firm under the heading “Experts” in this Registration Statement.
/s/ Friedman LLP |
| Marlton, New Jersey |
| September 16, 2022 |